While the presence of tumor cells in the circulation does not indicate that metastasis has occurred, it is the first crucial step in the cascade of hematogenic metastasis. Sensitive detection of such cells may have important therapeutic and prognostic implications. Reverse transcriptasepolymerase chain reaction (RT-PCR) has been applied to amplify mRNA sequences unique to breast cells, prostatic cells or other malignant cells in the circulation for early detection of micrometastases. 1, 2) However, few studies have reported the detection of transitional cell carcinoma (TCC) cells in blood or bone marrow by RT-PCR since mRNAs specific to urothelial cells have not been known. Very recently uroplakin Ib and III mRNA has been proposed as a specific marker for detection of TCC cells in the peripheral blood. 3) Cytokeratins (CKs) are intermediate-sized filaments that are characteristically present in epithelial cells and tumors, but have also been detected in many normal and neoplastic non-epithelial cells using immunohistochemical and RT-PCR techniques. In earlier studies using RT-PCR, CK 8 and CK 18 expression was found in normal blood and bone marrow, 4) and CK 19 mRNA was detected in normal blood. 5, 6) CK 20 expression, on the other hand, is almost entirely confined to gastric and intestinal epithelium, urothelium and Merkel cells, whether normal or malignant. 7, 8) The CK 20 RT-PCR assay has enabled detection of gastrointestinal cancer cells in bone marrow and venous blood. 5, [9] [10] [11] [12] Here we describe the detection of TCC cells in the peripheral blood by the CK 20 RT-PCR technique.
PATIENTS, MATERIALS, AND METHODS
Bladder cancer cell lines Three bladder cancer cell lines JTC 30, JTC 32, 13) and T24 14) were used in the study. JTC 30 and JTC 32 were established from well-differentiated and anaplastic TCC of the human bladder, respectively. JTC 30 and JTC 32 were cultured in DM 170 medium (Kyokuto Pharmaceutical Industrial Co., Tokyo) containing 10% fetal calf serum (FCS), and T24 was cultured in α minimum essential medium (MEM) (Life Technologies, Inc., Grand Island, NY) supplemented with 10% FCS. Patients The study population consisted of 40 patients having histologically diagnosed TCC of various stages; 13 patients with superficial TCC (Ta,T1,Tis N0 M0 in TNM classification 15) ), 21 with invasive and regional TCC (T2-T4 N0 M0), and 6 with metastatic TCC (Tx N1-N3 Mx or Tx Nx M1) ( Table I) . Twenty-five healthy adults served as a control group. Written informed consent was obtained from all of them. Blood samples Fourteen milliliter aliquots of peripheral blood were drawn from 40 patients and 25 healthy donors, and diluted with 14 ml of balanced salt solution. The mononuclear cell fraction was isolated as an intermediate layer by density centrifugation in the presence of FicollPaque (Pharmacia Biotech AB, Uppsala, Sweden) for 30 min at 400g. 16) RNA extraction Total RNA from cell lines and peripheral-blood mononuclear (PBMN) cell preparations was extracted using a commercially available RNA extraction kit in accordance with the recommendations of the manufacturer (Isogen; Nippon Gene, Toyama). Each RNA preparation was dissolved in 20 µl of RNase-free water. The amount and purity of RNA prepared from each sample was determined from the absorption at 260 nm and the absorption ratio of 260 to 280 nm (Gene Quant II; Pharmacia Biotech AB). RT-PCR cDNA was synthesized with a reverse transcription kit (Life Technologies, Inc.), using 4 µg of total RNA, 2 µl of random hexamers (50 ng/µl) and 1 µl (200 units) of SuperScript II in a total volume of 20 µl.
The CK 20-specific nested RT-PCR assay was carried out as previously described, 9) with PCR primers synthesized by Amersham Pharmacia Biotech, Tokyo. Table II .
The second RT-PCR was performed in the same manner as in Table II, To monitor cDNA synthesis, RT-PCR for β-actin was simultaneously performed with 1 µl of cDNA, and β-actin sense, 5′-CCAAGGCCAACCGCGAGAAGATGAC and antisense, 5′-AGGGTACATGGTGGTGCCGCCAGAC primers (0.5 µM each) in a volume of 50 µl. The product length of β-actin PCR was 587 bp.
One microgram of total RNA prepared from the bladder cancer cell line JTC 30 was used as a positive control. Contamination was routinely checked by RT-PCR assay of RNA-free samples (water control). All RT-PCR products were separated by electrophoresis in a 1.5% agarose gel in Tris-acetate-EDTA (TAE)-buffer and visualized by ethidium-bromide staining. The molecular weights were determined by using DNA molecular-weight marker 4 (Nippon Gene). Nucleotide-sequence determination The CK 20 RT-PCR product (485 bp) from positive controls and randomly chosen patients was sequenced using the ABI PRISM 377 DNA sequencer (Perkin Elmer, Foster, CA) as specified by the manufacturer. DNA sequences were aligned and analyzed using an Apple Macintosh computer. Statistical analysis The association between the CK 20 mRNA detection rate and tumor stages was examined by χ 2 test. (Table I) .
RESULTS

Sensitivity and specificity of CK 20 RT-PCR
Sequencing of the final PCR products revealed that the amplified products were consistently identical with the CK 20 cDNA sequence. The CK 20 signal was detected in PBMN cell fractions of some invasive urothelial cancer patients. The presence of circulating tumor cells does not necessarily predict subsequent metastatic disease. Most circulating tumor cells are destroyed rapidly, 17) and only a small number of cells may implant. In addition, the metastatic potential of individual tumor cells may vary. Therefore, the prognostic value of circulating tumor cells in urothelial cancer patients is still uncertain. It has been reported, however, that the survival rate of gastrointestinal cancer patients with CK 20 mRNA-positive bone marrow was significantly lower than that of negative patients. 10) Further clinical observation will reveal the prognostic value of detection of circulating urothelial tumor cells by CK 20 RT-PCR amplification.
No CK 20-specific signal was observed in patients with superficial urothelial cancers. Superficial bladder cancer is generally believed not to have metastatic potential and can be managed by organ-sparing treatment including transurethral resection of the tumor. The current result supports this modern urological policy.
In conclusion, the CK 20 RT-PCR assay is highly sensitive and specific, and therefore capable of detecting urothelial TCC cells circulating in the peripheral blood.
